417 filings
Page 7 of 21
8-K
4fhlmi4
3 Dec 20
Regulation FD Disclosure
4:01pm
EFFECT
4n8te3k
30 Nov 20
Notice of effectiveness
12:15am
CORRESP
naao6 vqyafysfe1vut
23 Nov 20
Correspondence with SEC
12:00am
UPLOAD
0opiuz 0z
19 Nov 20
Letter from SEC
12:00am
S-3
1or0bhx7
13 Nov 20
Shelf registration
4:01pm
CERT
z3rjj
9 Nov 20
Certification of approval for exchange listing
8:59am
8-K
lqj79lkbm24 rashv66
6 Nov 20
Rezolute Announces Uplisting to the Nasdaq Capital Market
4:01pm
8-A12B
qcq5d6nd4v3
4 Nov 20
Registration of securities on exchange
12:00am
D
ioa 2mhc0nkd4rwrd
22 Oct 20
$56.99M in equity / options / securities to be acquired, sold $41M, 12 investors
10:34am
8-K
kxrpv
9 Oct 20
Rezolute Announces $41 Million Private Placement with Leading Investment Firms and Prepares to Imminently Up-list to Nasdaq
7:02pm
NT 10-K
ovlwxu3w zr
29 Sep 20
Notice of late annual filing
6:04am
8-K
5ae2nep11 60dj
10 Sep 20
Rezolute, Inc. Welcomes Pharmaceutical Industry Leader Philippe Fauchet to its Board of Directors
4:01pm
8-K
npz x61dpo
2 Apr 20
Entry into a Material Definitive Agreement
4:34pm
EFFECT
24dalh9wsxl0s4fl 2i
9 Dec 19
Notice of effectiveness
12:15am
424B3
ieuq xuniu
6 Dec 19
Prospectus supplement
4:38pm